President Donald Trump signed an executive order Sept. 19 to modernize the flu vaccine development process.
The order will create a task force to promote new technologies that improve vaccine manufacturing and effectiveness. The goal is to reduce the nation's reliance on egg-based vaccine production, which is more time-consuming.
"Improving the speed of production will enable experts to better match vaccines to actively circulating viruses, an important piece of making the vaccines more effective," the Trump administration said in a news release.
Along with streamlining vaccine production, the executive order also aims to boost Americans' access to seasonal flu vaccine services.